MedWatch
Executive Summary
FDA Education and Outreach Director Mary Pat Couig and Policy & Programs Director Vicki Babb will manage MedWatch following the departure of Medical Director Stephen Goldman, MD, to Knoll Pharmaceuticals and Director Dianne Kennedy to the Office of Drug Evaluation IV (1"The Pink Sheet" Sept. 13, p. 3). FDA is searching for a permanent medical director and hopes to make that appointment before year-end
You may also be interested in...
FDA Quality Assurance Will Catalogue CDER Initiatives To Improve Processes
The Center for Drug Evaluation & Research's quality assurance unit plans to catalogue different initiatives within the center to standardize and improve processes under newly appointed Associate Director for Quality Assurance Mark Goldberger, MD.
FDA Quality Assurance Will Catalogue CDER Initiatives To Improve Processes
The Center for Drug Evaluation & Research's quality assurance unit plans to catalogue different initiatives within the center to standardize and improve processes under newly appointed Associate Director for Quality Assurance Mark Goldberger, MD.
FDA Senior Scientist Schwetz To Chair Deputy Commissioner Search Cmte.
FDA Senior Advisor for Science Bernard Schwetz, PhD, will serve as acting deputy commissioner as the agency searches for a permanent deputy for the position recently vacated by Michael Friedman, MD.